Not Yet Recruiting NA INTERVENTIONAL 1-arm
NCT06999785
Assessment of the Impact of Increased Production of Reactive Oxygen Species Produced During Repeated Sessions of Hyperbaric Oxygen Therapy in Patients Undergoing Radiotherapy for Neoplasia, on the Occurrence of DNA Damage (OXYBAR)
Sponsor: University Hospital, Angers
Conditions
Genotoxicity Hyperbaric Oxygen Malignancy
Interventions
Blood test
Updated 1 time since 2025 Last updated: May 23, 2025 Started: Sep 1, 2025 Primary completion: Sep 1, 2027 Completion: Nov 15, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06999785, this NA trial focuses on Genotoxicity and Hyperbaric Oxygen and remains actively recruiting participants. Sponsored by University Hospital, Angers, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University Hospital, Angers
Data source: University Hospital, Angers
For direct contact, visit the study record on ClinicalTrials.gov .